Peptic Ulcer Drugs Market Projected To Garner Significant Revenues By 2032
Market Overview:
The peptic ulcer drugs market is segmented into gastric ulcers, duodenal ulcers, and esophagitis. Gastric ulcers are the most common type of peptic ulcer, followed by duodenal ulcers. Esophagitis is inflammation of the esophagus, which can be caused by peptic acid reflux.
Global peptic ulcer drugs market size is expected to be worth around US$ 6.4 Bn by 2032 from US$ 4.6 Bn in 2022, growing at a CAGR of 3.5% during the forecast period from 2023 to 2032.